Page last updated: 2024-11-02

oxymetazoline and Osteoporosis

oxymetazoline has been researched along with Osteoporosis in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bundrick, JB1
Litin, SC1

Other Studies

1 other study available for oxymetazoline and Osteoporosis

ArticleYear
Clinical pearls in general internal medicine 2012.
    Mayo Clinic proceedings, 2013, Volume: 88, Issue:1

    Topics: Abdominal Pain; Administration, Intranasal; Adult; Aged; Atrial Fibrillation; Bone Density; Bronchod

2013